Isoxepac is a non-steroidal aryl acetic acid derivative, usually used as pharmaceutical intermediate. It is a non-steroidal anti-inflammatory with analgesic and antipyretic activity.
Isoxepac (also known) as HP-549 is a non-steroidal anti-inflammatory drug with analgesic activity. Isoxepac was studied in the clinical trial for the treatment of postoperative pain after knee surgery for meniscectomy. It was shown, that 200 mg of isoxepac would appear to be the minimal effective dose. In case of rheumatoid arthritis, isoxepac showed significantly fewer adverse effects.
Isoxepac is used for the treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.
Application: Pharmaceutical intermediates and organic synthesis
1.
For the treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.
(1)1kg/bag (1kg net weight, 1.2kg gross weight, packed in an aluminum foil bag; Outer: paper carton; Inner: double-layer PE)
(2)5kg/bag (5kg net weight, 5.2kg gross weight, packed in an aluminum foil bag; Outer: paper carton; Inner: double-layer PE)
(3)10kg/drum (10kg net weight, 12kg gross weight; Packed in a cardboard-drum with two plastic-bags inside; Drum Size: 310mm high, 400mm diameter)
(4)25kg/drum (25kg net weight, 28kg gross weight; Packed in a cardboard-drum with two plastic-bags inside; Drum Size: 510mm high, 350mm diameter)
(5)Customized package is available.
Pharmaceutical intermediates and organic synthesis
Indications/Functional Indications For the treatment of duodenal ulcers, gastric ulcers, reflux esophagitis, Zollinger-Ellison syndrome and other high gastric acid secretion diseases.
Copyright © 2019 Green Stone Swiss Co., Itd. | All Rights Reserved
Hello, please leave your name and email here before chat online so that we won't miss your message and contact you smoothly.